A Mason, BA MA - Journal of Clinical Pharmacy & Therapeutics, 2008 - pt.wkhealth.com Background and objective: The uptake of new medicines is slower in the UK than
in many other countries. Previous research found that cost and price have little
influence on general practitioner (GP) behaviour, but recent UK government ... Cited by 6 - Related articles - BL Direct - All 5 versions
A Schedlbauer, V Prasad, C Mulvaney, S … - Journal of the American Medical Informatics …, 2009 - Elsevier Alerts and prompts represent promising types of decision support in electronic
prescribing to tackle inadequacies in prescribing. A systematic review was
conducted to evaluate the efficacy of computerized drug alerts and prompts ... Cited by 4 - Related articles - All 4 versions
C Bryan, SA Boren - Informatics in Primary Care, 2008 - ingentaconnect.com Background The1999 InstituteofMedicine(IOM) report To Err is Human alerted the
healthcare industry and the public to the lack of consistency in the delivery of
quality care to the US population. Clinical decision support systems (CDSS) ... Cited by 1 - Related articles - All 2 versions
V Lewis, J Barnhart, JL Houghton, P Charney - International Journal of Cardiology, 2008 - Elsevier As part of an initiative to increase physician awareness about hypertension and
cardiovascular disease (CVD); we studied the effects of a pilot intervention on
the rates of referral for uncontrolled hypertension in an Ob-Gyn office. ... Related articles - All 2 versions
SA Pearson, A Moxey, J Robertson, I Hains, … - BMC Health Services Research, 2009 - biomedcentral.com 56 studies met our inclusion criteria, 38 addressing initiating, 23 monitoring
and three stopping therapy. At the time of initiating therapy, CDSSs appear to
be somewhat more effective after, rather than before, drug selection has ... Related articles - Cached - All 4 versions
AMBA MA - Journal of Clinical Pharmacy and Therapeutics - interscience.wiley.com Background and objective: The uptake of new medicines is slower in the UK than
in many other countries. Previous research found that cost and price have little
influence on general practitioner (GP) behaviour, but recent UK government ... Related articles